Healthcare specialist private equity firm ArchiMed has sold Austrian point-of-care testing specialist Eurolyser to the veterinary diagnostics arm of Mars Incorporated for a 6x return.
Healthcare specialist private equity firm ArchiMed has sold Austrian point-of-care testing specialist Eurolyser to the veterinary diagnostics arm of Mars Incorporated for a 6x return.